The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk ...

As the nation’s healthcare industry continues to struggle with workforce shortages and access gaps, Philips is expanding beyond its traditional medtech roots. The company isn’t just selling monitoring ...

Each year, the HLTH conference gives healthcare leaders a chance to gather and share ideas. The event also gives companies the chance to announce news — oftentimes about new products, partnerships and ...

Provider organizations are continuing to adopt AI tools across their departments and clinics, and ambient documentation startups are facing the challenge of differentiating themselves in a field ...

Numerous efforts have been made at the federal level to crack down on the opaque business practices of pharmacy benefit managers, from a lawsuit by the Federal Trade Commission to bills in Congress.

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

Agentic AI company Hyro closed a $45 million funding round led by Healthier Capital on Tuesday, bringing its fundraising total to $95 million. The New York City-based startup aims to fill healthcare’s ...

UnitedHealthcare has launched a national partnership with Aeroflow Health to provide virtual nutrition services to members, the companies announced last week. Asheville, North Carolina-based Aeroflow ...

With $50 billion set to flow to states over the next five years, CMS’ new Rural Health Transformation Program represents one of the largest federal investments in rural healthcare in decades. However, ...

Galapagos changed course earlier this year, announcing it no longer wanted to focus on cell therapy and would seek buyers for this business. After shopping around the assets for months, Galapagos ...